cussed.
Hypohidrotic ectodermal dysplasia (HED) was first described by Thurnam' A whole back sweat test was carried out on all thre-e sisters and was normal. Dental x rays were examined from all four women. There was definite taurodontism in subject HII1 and a suggestion of taurodontism in subjects I12, II-3, and II4.
Using the criteria of two missing or abnormally shaped teeth as diagnostic of carrier status when there is a family history, all three sisters were diagnosed as carriers. The accessory nipple in subject II-1 was further evidence that she is a gene carrier.
DNA ANALYSIS
The probes used to detect restriction fragment length polymorphisms are shown in the table. Details of all of these probes are given in the report of the Ninth International Workshop on Human Gene Mapping. 6 The probe pXG3'7 was used to confirm paternity. DNA extraction, restriction endonuclease digestion, electrophoresis, blotting, and hybridisation were carried out by standard procedures.'8
Results
The haplotype results are shown in the table. The order of loci (DXS146-DXSI-DXS106-DXS159-PGKI-DXS72-DXYSI-DXS3-DXS94-DXS17) is based on studies of somatic cell hyrbrids, deletions, and recombinant chromosomes.' 14 19 20 Recombinations have occurred within this haplotype in four out of six female meioses. In the meiosis leading to II a recombination has occurred between DXS72 and DXYSI. In the meiosis leading to II-4 a recombination has occurred between DXYSI and DXS3. In the meiosis leading to III 1 a recombination has occurred between DXYSI and DXS94. Finally, in the meiosis leading to III-2 a recombination has occurred between DXS106 and PGKI.
The three sisters have inherited the same maternal X chromosome at the DXYSI locus, but not for the haplotype from DXS72 to DXS146 or for the DXS3 locus, the first locus tested distal to DXYSI. Their mother is not heterozygous for polymorphisms at DXS94 or DXS17. The affected boy 1111 has inherited the region detected by DXYSI from his grandfather. The two normal boys in generation III also inherited this region of the X chromosome from their grandfather.
The meiosis leading to the affected male was informative for the polymorphisms detected by cpX289 and pSPT/PGK at DXS159 and PGKI. The affected male inherited the grandpaternal alleles at both of these loci. The two normal males in genera-
The probes used at each loci are listed as a haplotype. +indicates the presence and -absence ofa polymorphic site. The numbering ofthe subjects corresponds to the pedigree shown in thefigure. The paternal haplotype is shown on the rightfor each ofthe females in generation II. The affected male in this family has many of the classical features of X linked HED but is not completely typical because his whole back sweat test and finger tip impressions show that he does have sweat pores. His hair, teeth, periorbital pigmentation, and absence of nipples, however, all support the diagnosis. Renal anomalies have not been described before in the condition and were considered a coincidental finding. The most likely diagnosis in this family, however, remains X linked HED. If this is the case it could be a new mutation in the affected male, a new mutation in his mother, or, as thought on clinical grounds, all three sisters could be gene carriers.
The mother of the affected boy is heterozygous for the polymorphisms detected by cpX289 and pSPT/PGK. Her paternity was checked using pXG3. In addition, the paternal allele for pSPT/PGK is certain as her mother is homozygous for this probe. The affected male has received the grandpaternal allele for both of these probes. One explanation is that she carries a new mutation on the paternal X chromosome. If this is correct then either her two sisters are carriers as a result of gonadal mosaicism, or they are not carriers despite the dental abnormalities. The two normal sons of II-4, assigned a carrier on the basis of dental abnormalities, have inherited the grandpaternal haplotype for these two probes and, therefore, gonadal mosaicism alone does not account for all of the findings. This means that if II-1 carries a new mutation on the paternal X chromosome, which is compatible with the mapping information on HED, then her sisters are not carriers.
Alternative explanations for III receiving the grandpaternal allele for cpX289 and pSPT/PGK are a double recombination between these probes or that the disease in this family is at a separate locus. Data from other family members are not consistent with a disease localisation between cpX289 and pSPT/PGK as the three sisters have not inherited the same maternal haplotype for probes around this region.
The prior probabilities of the women being carriers of HED are greater than the probability of their dental abnormalities being incidental findings, as only 0-6% of the population have three absent permanent teeth and only 2% have two absent permanent teeth, excluding third molars.24 If all three sisters are carriers of the disorder, then a second locus for HED remains the most likely explanation. However, families from Britain, Switzerland, Finland, Denmark, France, and the United States have been studied without any suggestion of non-allelic heterogeneity.
Two recombinations have been reported between the disease locus and DXS159. The first recombinant subject9 was a 56 year old female who was assigned a carrier because she had dry skin and a slight decrease in sweat pores. The second recombinant subject was an edentulous 60 year old female who gave a history of two missing permanent teeth but whose dental records were not available for review.1°The meiosis leading to this female also showed a recombination with PGKI. If these females are excluded from the analysis, there have been no recombinations between the disease locus and DXS159 or PGKI. It seems probable that these two women are not carriers of the disease. This highlights the difficulties of accurate assignment of carrier status.
In conclusion, there are two possible explanations of the haplotype results in this family. The first possibility is that the sisters II-3 and II-4 are not gene carriers and the second possibility is that there is nonallelic heterogeneity. Either of these explanations raises concern about counselling of females in families with HED and use of linked DNA markers for predictive testing. We suggest that ifDNA information from a woman is used to assign phase within a family then more stringent criteria are required for diagnosis of carrier state.
As this family raises the possiblity of a second locus for HED the use of cpX289 and pSPT/PGK for clinical testing should be treated with caution in small families where it is not possible to show that the disease is segregating with the region Xql 1-q 13. 
